Updated - NSW Health Public Hospital Supply Contract

• NSW Health contract awarded to AlgoraeRx
• Initial term of three years with two one-year extensions
• Strategically significant but no immediate financial impact expected

Algorae Pharmaceuticals Ltd, through its division AlgoraeRx, has been awarded a contract by NSW Health for the supply of a pharmaceutical product to public hospitals and other eligible customers. The contract, which is not exclusive, has an initial term of three years with two optional one-year extensions. AlgoraeRx was selected following a competitive tender process, satisfying NSW Health's requirements. The product's identity is commercial-in-confidence, and onboarding and rollout are underway with first supply expected in Q4 2026. While the contract is strategically significant, Algorae Pharmaceuticals does not expect it to have a material impact on its revenue in the current calendar year.